Overview: Dengue NS1 Antigen TestIntroduction: The Dengue NS1 Antigen Test detects dengue NS1 antigen, confirming early infection causing fever or joint pain. Following 2023 WHO guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding early diagnosis, treatment, and improving outcomes in virology for patients with suspected acute dengue infections.
Other Names: Dengue NS1 Assay, Early Dengue Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: Dengue NS1 testing began in the 2000s with advances in antigen detection. Rapid immunoassays emerged in the 2010s, improving early diagnostic accuracy.
Purpose: Diagnoses early dengue infection, guides supportive care, and monitors antigen presence in patients with fever or joint pain.
Test Parameters: 1. Dengue NS1 Antigen
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like fever or joint pain, and list recent travel to dengue-endemic areas.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, joint pain, or travel to dengue-endemic areas. Include current medications, especially antipyretics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for supportive care.
Procedural Considerations: Uses an immunoassay (e.g., lateral flow assay) to detect dengue NS1 antigen. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Early infection or low antigen levels may cause false negatives. Cross-reactivity with other flaviviruses may occur.
Clinical Significance: Positive NS1 results confirm early dengue infection, prompting supportive care. Negative results may require IgM or PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation.
Additional Supporting Tests: Dengue IgM/IgG, PCR, or complete blood count to confirm infection or assess complications.
Test Limitations: False negatives may occur after early infection phase. Results require clinical correlation.
References: WHO Dengue Guidelines, 2023; Clinical Infectious Diseases, Guzman MG, 2022.
